| Tag | Content |
|---|
EnhancerAtlas ID | HS091-17275 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr16:50342700-50343450 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFKB1 | MA0105.4 | chr16:50342828-50342841 | GGGGGGTTCCCCT | - | 6.09 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_09438 | chr16:50342847-50352933 | CD14 | | SE_11181 | chr16:50341885-50344578 | CD20 | | SE_20409 | chr16:50343052-50344199 | CD56 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH16I050309 | chr16 | 50343290 | 50345065 |
|
Enhancer Sequence | CTGGTGGGTC CCGTGGTGGG GAGGCAGGCC TCCGGGGTAG AGGGAGACCT CCAGATTTGG 60
GACGCCTACA ATGTGGCCTT AAAAGCTGCC TCTGGTTGTC CTCTCCCCCG AGCTCAGCAG 120
GTGGATGTGG GGGGTTCCCC TTTGTACACT CAGGGCTCCT CACCTTTGGG TTCTCAAATG 180
CGGACTTTGG GGGCCCAGAG AGCTTGTGTG GCCAGCTCCA GGAGGATGTG ATGCCTTGAG 240
CCACCACATC CTGACATCCC ATTCATTCTT CACGGCCCTT CTGAGACTCA GTTTCCCCTC 300
TCAGGGATGA ACCCTTGCTC CTCTGCTGGG GCTCAGAGGC TCAGTGCTGC AGAAAGCAGC 360
CTGCGGGACA CTTGTCCACC TCTCTCCCAG ACCCCGCATC CTGGGCTAGG GCCTCTCCCT 420
CACCTCTCTG CCCCGGACCC TGGGTTTTTG GAATGTGTTC CTGTGACCAC CTCCCTCAGG 480
GTCACCTGGG GAGGCTGAAA ATGTTGGTCC CGGCCCCTCC CCCTGGCTGC TGCCGCTCTG 540
GGGGTGTCTG CACCCTCATC TCCTAGCCCC TCTGCCCTCT GAACCTGACG GCTGCTGTGG 600
GGAGTCGGCA CGGCGGCTTG AGCCGTGCTC AGAGCTGATC CCAACGTGAA ACCTCAGGCT 660
GCTGTGATAC TCATGGTTGC CTGGGGCCCA CCTTGCATGG CTTGGGCAGG TTCCAGCGTT 720
CTTGTCCCTG GACTGATGGG GACCTGTCTC 750
|
